Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Soluble Epoxide Hydrolase in Atherosclerosis
2010
EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease
2011
Recommendations for transoesophageal echocardiography: EACVI update 2014
2014
Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair
2012
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Valvular Heart Disease
1997
One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry
2015
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Percutaneous Mitral Valve Interventions in the Real World
2013
Coronary artery stents: a rapid systematic review and economic evaluation
2004
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Pathology of Drug-Eluting Stents in Humans
2006 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Percutaneous bypass: subintimal recanalization of peripheral occlusive disease with IVUS guided luminal re-entry
2004
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007
2012
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
2009
Novel Intravascular Ultrasound-Guided Method to Create Transintimal Arterial Communications: Initial Experience in Peripheral Occlusive Disease and Aortic Dissection
2004
SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement. Part II. Mitral Valve
2014
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
2011
The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation
2015
Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: Clinical and angiographic study
1994
Mechanical Load Enhances Procollagen Processing in Dermal Fibroblasts by Regulating Levels of Procollagen C-Proteinase
1999
Guidelines for Percutaneous Coronary Interventions
2005
Correction of Mitral Regurgitation in Nonresponders to Cardiac Resynchronization Therapy by MitraClip Improves Symptoms and Promotes Reverse Remodeling
2011
Peri-procedural myocardial injury: 2005 update
2005
Epidemiology of valvular heart disease in the adult
2011
SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR)
2012
Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk Patients
2014
Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch
2004
Third Universal Definition of Myocardial Infarction
2012 Standout
Recommendations for transoesophageal echocardiography: update 2010
2010
Survival of Transcatheter Mitral Valve Repair Compared With Surgical and Conservative Treatment in High-Surgical-Risk Patients
2014
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Secondary Mitral Regurgitation in Heart Failure
2015
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases
2011
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Selective ablation of atheromas using a flashlamp-excited dye laser at 465 nm.
1986
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
1987 Standout
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
1987 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
Intravenous short-term infusion of streptokinase in acute myocardial infarction.
1983
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
2003 Standout
Extracellular Matrix Remodeling in Heart Failure
1997
Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
1984
Mechanisms of Plaque Formation and Rupture
2014 Standout
Intravenous streptokinase in evolving acute myocardial infarction
1984
Acute stroke: evaluation and treatment.
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
One-Year Outcomes After MitraClip for Functional Mitral Regurgitation
2018
Factors influencing probability of reperfusion with intracoronary ostial infusion of thrombolytic agent in patients with acute myocardial infarction.
1985
Coronary Microembolization
2009
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
1986 Standout
Biomaterials & scaffolds for tissue engineering
2011 Standout
High-dose, brief intravenous streptokinase early in acute myocardial infarction
1982
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts
2002
Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
1983
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Coronary Plaque Disruption
1995 Standout
Transient giant negative T wave in acute anterior myocardial infarction predicts R wave recovery and preservation of left ventricular function.
1996 StandoutNobel
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 Standout
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Intracoronary streptokinase in clinical practice
1982
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Mechanisms of Pulsed Laser Ablation of Biological Tissues
2003 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure−Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
2010
Thrombosis Modulates Arterial Drug Distribution for Drug-Eluting Stents
2005
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
1985 Standout
Works of Reginald Low being referenced
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
2006
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches
2009
Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: The Direct Flow Medical aortic valve
2010
Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload
1994
4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation
2013
Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: Results from the multicenter X‐sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X‐TRACT) study
2003
Catheter‐based coronary bypass: A development update
2003
Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries
2003
Percutaneous Mitral Repair With the MitraClip System
2009
Comparison of PRE-dilatation vs Direct stenting In Coronary Treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial)
2001
Determinants of beneficial coronary streptokinase therapy in acute myocardial infarction: Success and rapidity of thrombolysis depends on minimal time from symptom onset to treatment
1982
Limitations, risks and complications of laser recanalization: A cautious approach warranted
1985
Efficacy of percutaneous transluminal coronary recanalization utilizing streptokinase thrombolysis in patients with acute myocardial infarction
1981